People · Operator
Named in public records as an officer, director or promoter · active 2011–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Molecular Imaging, Inc. | — | Biotechnology | Series A | $12.0M | $55.5M | 2011 |
| Santiste Medical Inc. | — | Biotechnology | Pre-Seed | $186K | $10.3M | 2018 |
Mark Eisenach at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Eisenach on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Gross | 1 | 9 |
| Stephen Sullivan | 1 | 6 |
| Peter Shagory | 1 | 5 |
| Nicole Walker | 1 | 4 |
| Walter Greenblatt | 1 | 2 |
| Thomas Ludlam | 1 | 1 |
| James Dougherty | 1 | 1 |
| Steven Sullivan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.